A 9-valent HPV vaccine against infection and intraepithelial neoplasia in women.
Joura EA, Giuliano AR, Iversen OE, Bouchard C, Mao C, Mehlsen J, Moreira ED Jr, Ngan Y, Petersen LK, Lazcano-Ponce E, Pitisuttithum P, Restrepo JA, Stuart G, Woelber L, Yang YC, Cuzick J, Garland SM, Huh W, Kjaer SK, Bautista OM, Chan IS, Chen J, Gesser R, Moeller E, Ritter M, Vuocolo S, Luxembourg A; Broad Spectrum HPV Vaccine Study.
N Engl J Med. 2015 Feb 19;372(8):711-23. doi: 10.1056/NEJMoa1405044.
Vaccination against HPV-16 oncoproteins for vulvar intraepithelial neoplasia.
Kenter GG, Welters MJ, Valentijn AR, Lowik MJ, Berends-van der Meer DM, Vloon AP, Essahsah F, Fathers LM, Offringa R, Drijfhout JW, Wafelman AR, Oostendorp J, Fleuren GJ, van der Burg SH, Melief CJ.
N Engl J Med. 2009 Nov 5;361(19):1838-47. doi: 10.1056/NEJMoa0810097.
Four year efficacy of prophylactic human papillomavirus quadrivalent vaccine against low grade cervical, vulvar, and vaginal intraepithelial neoplasia and anogenital warts: randomised controlled trial.
FUTURE I/II Study Group; Dillner J, Kjaer SK, Wheeler CM, Sigurdsson K, Iversen OE, Hernandez-Avila M, Perez G, Brown DR, Koutsky LA, Tay EH, García P, Ault KA, Garland SM, Leodolter S, Olsson SE, Tang GW, Ferris DG, Paavonen J, Lehtinen M, Steben M, Bosch FX, Joura EA, Majewski S, Muñoz N, Myers ER, Villa LL, Taddeo FJ, Roberts C, Tadesse A, Bryan JT, Maansson R, Lu S, Vuocolo S, Hesley TM, Barr E, Haupt R.
BMJ. 2010 Jul 20;341:c3493. doi: 10.1136/bmj.c3493.
Safety and efficacy of topical artesunate for the treatment of vulvar intraepithelial neoplasia 2/3.
Michener CM, Ricci S, AlHilli M, Beffa L, Debernardo R, Waggoner SE, Brainard J, Plesa M, Belinson JL, Trimble CL.
Gynecol Oncol. 2023 Nov;178:102-109. doi: 10.1016/j.ygyno.2023.10.003. Epub 2023 Oct 14.
Vulvar intraepithelial neoplasia treated with cavitational ultrasonic surgical aspiration.
Miller BE.
Gynecol Oncol. 2002 Apr;85(1):114-8. doi: 10.1006/gyno.2001.6577.
Safety and efficacy of topical cidofovir to treat high-grade perianal and vulvar intraepithelial neoplasia in HIV-positive men and women.
Stier EA, Goldstone SE, Einstein MH, Jay N, Berry JM, Wilkin T, Lee JY, Darragh TM, Da Costa M, Panther L, Aboulafia D, Palefsky JM.
AIDS. 2013 Feb 20;27(4):545-51. doi: 10.1097/QAD.0b013e32835a9b16.
A randomized phase II trial of indole-3-carbinol in the treatment of vulvar intraepithelial neoplasia.
Naik R, Nixon S, Lopes A, Godfrey K, Hatem MH, Monaghan JM.
Int J Gynecol Cancer. 2006 Mar-Apr;16(2):786-90. doi: 10.1111/j.1525-1438.2006.00386.x.
Lectins in the vulva. II. Vulvar intraepithelial neoplasia and squamous cell carcinoma.
Naik R, Cross P, de Barros Lopes A, Robson P, Monaghan J.
Int J Gynecol Pathol. 1998 Apr;17(2):162-70. doi: 10.1097/00004347-199804000-00012.
A phase I trial of a human papillomavirus (HPV) peptide vaccine for women with high-grade cervical and vulvar intraepithelial neoplasia who are HPV 16 positive.
Muderspach L, Wilczynski S, Roman L, Bade L, Felix J, Small LA, Kast WM, Fascio G, Marty V, Weber J.
Clin Cancer Res. 2000 Sep;6(9):3406-16.
Photodynamic therapy of vulvar and vaginal condyloma and intraepithelial neoplasia using topically applied 5-aminolevulinic acid.
Fehr MK, Hornung R, Degen A, Schwarz VA, Fink D, Haller U, Wyss P.
Lasers Surg Med. 2002;30(4):273-9. doi: 10.1002/lsm.10048.
